Aprea Therapeutics Inc (APRE) — Financial Flexibility Index
Aprea Therapeutics Inc (APRE) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-2.76 Million (operating CF $-2.76 Million minus capex $0.00) represents -1% of total liabilities ($5.30 Million). Check APRE tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aprea Therapeutics Inc Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Aprea Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see APRE cash flow conversion.
Annual Financial Flexibility Index for Aprea Therapeutics Inc (2007–2025)
Year-by-year free cash flow to debt coverage for Aprea Therapeutics Inc. Explore APRE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.69x | $-12.89 Million | $-12.89 Million | $3.49 Million | ▼ -27.4% |
| 2024 | -2.90x | $-13.54 Million | $-13.56 Million | $4.67 Million | ▼ -5.2% |
| 2023 | -2.76x | $-12.08 Million | $-12.18 Million | $4.39 Million | ▲ +50.3% |
| 2022 | -5.54x | $-25.01 Million | $-25.01 Million | $4.51 Million | ▼ -7.6% |
| 2021 | -5.15x | $-37.69 Million | $-37.69 Million | $7.32 Million | ▼ -90.0% |
| 2020 | -2.71x | $-41.78 Million | $-41.80 Million | $15.41 Million | ▲ +4.8% |
| 2019 | -2.85x | $-26.68 Million | $-26.71 Million | $9.36 Million | ▼ -2094.8% |
| 2018 | -0.13x | $-15.25 Million | $-15.25 Million | $117.46 Million | ▲ +43.9% |
| 2017 | -0.23x | $-14.00 Million | $-14.00 Million | $60.53 Million | ▲ +70.4% |
| 2007 | -0.78x | $-1.90 Million | $-1.90 Million | $2.43 Million | — |